| JPM EUROPE EQUITY PLUS C (PERF) (ACC) USD | RVI EUROPA | 20,14% | 69,94% | 94,13% | 179,34% |
| JPM EUROPE EQUITY PLUS I (PERF) (ACC) EUR | RVI EUROPA | 20,23% | 69,47% | 94,26% | 179,30% |
| BARINGS GLOBAL EMERGING MARKETS FUND I GBP CAP | RVI EMERGENTES | 49,41% | 71,22% | 58,59% | 179,28% |
| CAPITAL GROUP GLOBAL EQUITY FUND (LUX) Z USD | RVI GLOBAL | 15,69% | 43,08% | 56,32% | 179,26% |
| CANDRIAM EQUITIES L EMERGING MARKETS R CAP EUR | RVI EMERGENTES | 54,20% | 87,62% | 40,13% | 179,25% |
| DWS INVEST LATIN AMERICAN EQUITIES USD LC | RVI LATINOAMÉRICA | 27,90% | 38,04% | 59,21% | 179,18% |
| UBS (LUX) KEY SELECTION SICAV - EUROPEAN EQUITY VALUE OPPORTUNITY (EUR) Q-ACC | RVI EUROPA CRECIMIENTO | 24,79% | 61,28% | 95,61% | 179,17% |
| ABRDN SICAV I-JAPANESE SUSTAINABLE EQUITY FUND A ACC EUR HEDGED | RVI JAPÓN | 52,80% | 105,63% | 112,22% | 179,13% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | RVI BIOTECNOLOGÍA | 47,01% | 43,32% | 64,63% | 179,11% |
| GAM MULTISTOCK JAPAN SPECIAL SITUATIONS A CHF HEDGED | RENT. ABSOLUTA. | 47,78% | 65,26% | 96,82% | 179,09% |
